Prescription Trends in Dementia Care: A 10‐Year Review from a Brazilian Public Memory Clinic Perspective
Our findings showed that 86.6% of patients accessed at least one drug. However, less than 50% of them utilized dementia-specific medications, which may be due to their indication being primarily for Alzheimer's disease or challenges in accessing these therapies within the Brazilian public health system. With the aim of enhancing therapeutic strategies and addressing existing gaps, further analyses will help elucidate the characteristics of these patients, their prescription patterns, and the barriers to improving dementia care.
Authors
- Lucas Porcello Schilling (ORCID: https://orcid.org/0000-0002-9923-6982)
- Cristiano Schaffer Aguzzoli (ORCID: https://orcid.org/0000-0002-7378-3830)
- Fernando Jacob Lazzaretti
- Carlos Gustavo Heyer Lokschin
Institutions
- Instituto do Cérebro (BR)
- Hospital São Lucas da PUCRS (BR)
- Global Brain Health Institute (US)
- Pontifícia Universidade Católica do Rio Grande do Sul (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70860_106549
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00